BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25950642)

  • 1. Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.
    Boardman HF; Delaney BC; Haag S
    Curr Med Res Opin; 2015; 31(7):1309-18. PubMed ID: 25950642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors.
    Boardman HF; Heeley G
    Int J Clin Pharm; 2015 Oct; 37(5):709-16. PubMed ID: 26100836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based treatment of frequent heartburn: the benefits and limitations of over-the-counter medications.
    McRorie JW; Gibb RD; Miner PB
    J Am Assoc Nurse Pract; 2014 Jun; 26(6):330-9. PubMed ID: 24825071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonprescription Heartburn Medications for Adults.
    Vordenberg SE
    JAMA; 2023 Oct; 330(15):1499. PubMed ID: 37773509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of over-the-counter proton pump inhibitors for patient counseling by pharmacists.
    Simonson W
    Am J Ther; 2013; 20(6):676-84. PubMed ID: 21642828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
    Quartarone G
    Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New algorithm for the treatment of gastro-oesophageal reflux disease.
    Tytgat GN; McColl K; Tack J; Holtmann G; Hunt RH; Malfertheiner P; Hungin AP; Batchelor HK
    Aliment Pharmacol Ther; 2008 Feb; 27(3):249-56. PubMed ID: 17973975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.
    Holtmann G; Bigard MA; Malfertheiner P; Pounder R
    Int J Clin Pharm; 2011 Jun; 33(3):493-500. PubMed ID: 21472476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community.
    Watson DI; Lally CJ
    World J Surg; 2009 Jan; 33(1):88-94. PubMed ID: 18949510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist.
    Armstrong D; Nakhla N
    Pharm Pract (Granada); 2016; 14(4):868. PubMed ID: 28042359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the primary care provider in the diagnosis and management of heartburn.
    Kushner PR
    Curr Med Res Opin; 2010 Apr; 26(4):759-65. PubMed ID: 20095795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.